US45845P1084 - ICPT - A1J5U0 (XNMS)
INTERCEPT PHARMACEUTICALS INC Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 71,79 % | -72,56 % |
Firmenprofil zu INTERCEPT PHARMACEUTICALS INC Aktie
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in New York, New York.
Investierte Fonds
Folgende Fonds haben in INTERCEPT PHARMACEUTICALS INC investiert:
Fonds | Vol. in Mio 15,59 | Anteil (%) 0,04 % |
Unternehmensdaten zur INTERCEPT PHARMACEUTICALS INC Aktie
Name INTERCEPT PHARMACEUTICALS INC
Firma Intercept Pharmaceuticals, Inc.
Symbol ICPT
Website https://www.interceptpharma.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A1J5U0
ISIN US45845P1084
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Jerome B. Durso
Marktkapitalisierung 795 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,3 T
Adresse 10 Hudson Yards, 10001 New York
IPO Datum 2012-10-11
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ICPT |
Weitere Aktien
Investoren die INTERCEPT PHARMACEUTICALS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024